Helping young adults with cannabis use disorder through text message support
Treating Young Adult Cannabis Use Disorder with Text Message-Delivered Peer Network Counseling
This study is looking at how young adults aged 18 to 25 who have trouble with cannabis use can get help through friendly text messages and peer support, making it easier and more private for them to manage their cannabis use and improve their lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tennessee Knoxville NIH-funded |
| Lab location | 1 site (Knoxville, United States) |
| Project ID | NIH-10618328 on NIH RePORTER |
What this research studies
This research focuses on young adults aged 18 to 25 who struggle with cannabis use disorder (CUD). It utilizes a text message-based counseling approach that connects participants with peer support networks, aiming to provide a more private and accessible form of treatment. The study explores how social influences and environmental factors affect cannabis use and treatment outcomes, leveraging technology to enhance engagement and effectiveness. Participants will receive tailored support through their mobile devices, making it easier for them to seek help without the stigma often associated with traditional treatment methods.
Who could benefit from this research
Good fit: Ideal candidates for this research are young adults aged 18 to 25 who are experiencing issues related to cannabis use disorder.
Not a fit: Patients outside the age range of 18 to 25 or those not struggling with cannabis use disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a novel and effective treatment option for young adults dealing with cannabis use disorder.
How similar studies have performed: Other research has shown promise in using digital interventions for substance use disorders, indicating potential success for this approach.
Where this research is happening
Knoxville, United States
- University of Tennessee Knoxville — Knoxville, United States (Active)
Researchers
- Principal investigator: Mason, Michael Jon — University of Tennessee Knoxville
- Study coordinator: Mason, Michael Jon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.